Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYTOKINETICS INCCYTK · Entity 3528 | Director · President & CEO | October 12, 2026 | October 13, 2026 |
| Gamida Cell Ltd.GMDA · Entity 94655 | Director | February 08, 2023 | February 11, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYTOKINETICS INC
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 278,544 |
Ending reported balance
After 2026-10-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-12 · Exercise / conversion · Acquired 7,500 · Balance 286,044 Row 2 · 2026-10-12 · Sale · Disposed 7,500 · Balance 278,544 |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.60 · Expires 2027-02-28 | Direct | 141,745 |
Reported balance
After 2026-10-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-12 · Exercise / conversion · Disposed 7,500 · Balance 141,745 |
| Common StockSEC Table I · non-derivative | Indirectby Trust 1. Beneficial Ownership disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,083 F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
| Common StockSEC Table I · non-derivative | Indirectby Trust 2. Beneficial Ownership Disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,083 F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
Gamida Cell Ltd.
Report date February 08, 2023 · Filed February 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 96,500 |
Ending reported balance
After 2023-02-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-02-08 · Grant · Acquired 28,300 · Balance 82,300 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. Row 2 · 2023-02-08 · Grant · Acquired 14,200 · Balance 96,500 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 56,600 |
Reported balance
After 2023-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-08 · Grant · Acquired 56,600 · Balance 56,600 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 28,300 |
Reported balance
After 2023-02-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-02-08 · Grant · Acquired 28,300 · Balance 28,300 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.
F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 14, 2021 Filed Oct 15, 2021 20:37 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.00 | $30,000.00 |
DisclosureSEC source: 0001061983-21-000237 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000217 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,143 Underlying: Common Stock · 5,000 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $34.01 | $170,063.50 |
DisclosureSEC source: 0001061983-21-000217 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.00 | $30,000.00 |
DisclosureSEC source: 0001061983-21-000217 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:25 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,065 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000214 · edgardoc.xml · derivative · entry 8 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,065 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:25 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 935 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000214 · edgardoc.xml · derivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,143 Underlying: Common Stock · 935 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:25 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,065 | $32.66 | $132,776.31 |
DisclosureSEC source: 0001061983-21-000214 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:25 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 4,065 | $6.30 | $25,609.50 |
DisclosureSEC source: 0001061983-21-000214 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:25 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 935 | $32.66 | $30,540.19 |
DisclosureSEC source: 0001061983-21-000214 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:25 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 935 | $6.00 | $5,610.00 |
DisclosureSEC source: 0001061983-21-000214 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:24 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000210 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:24 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $33.12 | $165,577.00 |
DisclosureSEC source: 0001061983-21-000210 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:24 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000210 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000206 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $31.14 | $155,711.50 |
DisclosureSEC source: 0001061983-21-000206 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000206 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 20:19 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000202 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 20:19 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $29.12 | $145,604.00 |
DisclosureSEC source: 0001061983-21-000202 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 20:19 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000202 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 21:02 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000198 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 21:02 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $29.82 | $149,121.00 |
DisclosureSEC source: 0001061983-21-000198 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 21:02 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000198 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| July 06, 2021 Filed Jul 6, 2021 21:42 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000178 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| July 06, 2021 Filed Jul 6, 2021 21:42 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $20.13 | $100,668.00 |
DisclosureSEC source: 0001061983-21-000178 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| July 06, 2021 Filed Jul 6, 2021 21:42 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000178 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 21:24 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000160 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 21:24 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $21.37 | $106,838.00 |
DisclosureSEC source: 0001061983-21-000160 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 21:24 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000160 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 22:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000156 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 22:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $20.61 | $103,043.50 |
DisclosureSEC source: 0001061983-21-000156 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,563 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 22:28 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000156 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000151 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $23.71 | $118,548.50 |
DisclosureSEC source: 0001061983-21-000151 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,859 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000151 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| May 07, 2021 Filed May 7, 2021 22:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000124 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| May 07, 2021 Filed May 7, 2021 22:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $23.21 | $116,041.00 |
DisclosureSEC source: 0001061983-21-000124 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,859 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| May 07, 2021 Filed May 7, 2021 22:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000124 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 21:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000122 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 21:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $25.87 | $129,361.00 |
DisclosureSEC source: 0001061983-21-000122 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,859 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 21:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000122 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 21:31 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000111 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,065 Underlying: Common Stock · 5,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 21:31 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $23.56 | $117,813.00 |
DisclosureSEC source: 0001061983-21-000111 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,859 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 21:31 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $6.30 | $31,500.00 |
DisclosureSEC source: 0001061983-21-000111 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:13 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 566 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001061983-21-000087 · edgardoc.xml · derivative · entry 8 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,065 Underlying: Common Stock · 566 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:13 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,434 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000087 · edgardoc.xml · derivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,434 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:13 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 566 | $25.19 | $14,260.09 |
DisclosureSEC source: 0001061983-21-000087 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,859 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:13 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 566 | $6.30 | $3,565.80 |
DisclosureSEC source: 0001061983-21-000087 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:13 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,434 | $25.19 | $111,712.41 |
DisclosureSEC source: 0001061983-21-000087 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,859 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:13 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 4,434 | $6.00 | $26,604.00 |
DisclosureSEC source: 0001061983-21-000087 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 08, 2021 Filed Mar 8, 2021 23:10 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000064 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,434 Underlying: Common Stock · 5,000 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.